Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
about
Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort studyImpact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real timeStaphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control studyVancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections.Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand.Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort studyImmune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality.Active immunization with an octa-valent Staphylococcus aureus antigen mixture in models of S. aureus bacteremia and skin infection in miceEpidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study.Predictors of in-hospital mortality in elderly patients with bacteraemia admitted to an Internal Medicine ward.Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection.Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adultsPredictors of mortality in Staphylococcus aureus BacteremiaOutcome of Community-Acquired Staphylococcus aureus Bacteraemia in Patients with Diabetes: A Historical Population-Based Cohort StudyTetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late MortalityUnderlying disorders and their impact on the host response to infection.Patterns and predictors of short-term death after emergency department discharge.A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients.Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.Racial differences in the impact of comorbidities on survival among elderly men with prostate cancer.Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.Clonal differences in Staphylococcus aureus bacteraemia-associated mortality.Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections.The Pitt Bacteremia Score, Charlson Comorbidity Index and Chronic Disease Score are useful tools for the prediction of mortality in patients with Candida bloodstream infection.Microbiological features and clinical impact of the type VI secretion system (T6SS) in Acinetobacter baumannii isolates causing bacteremia.[Antibiotic stewardship and Staphylococcus aureus Bacteremia].Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?Impact of a computerized alert system for bacteremia notification on the appropriate antibiotic treatment of Staphylococcus aureus bloodstream infections.Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand.Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital.Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality.Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes.A binational cohort study of ventilator-associated pneumonia in Denmark and Australia.
P2860
Q28750538-5E60B758-B132-4FC9-8D39-9FB755383861Q33373058-686EB0A1-7127-4C79-8B8F-02B52AAF53DEQ33643822-990CB7CA-FF24-4F49-BE3A-68C2F66D68BBQ33945397-10F5D18B-E730-486E-9ABB-28FB327EA481Q34190342-2398A338-A905-4195-B4A6-4920C8C32E19Q34569092-8E05A2B6-5CA3-4BEA-8D55-743687D6AE2CQ34726682-412B637E-194E-46CA-BB88-8E6BB88B5E8BQ35077842-F85BC059-E574-4973-B2DC-A56526A22273Q35088590-9716F296-F576-4F91-A642-C256C6F048E0Q35116935-053E58F1-44C1-48E4-93BD-6A443459C97EQ35153754-71FD280B-F29B-4FAA-AC9D-E135C7A7F898Q35509100-8C0073C5-43F2-4C6D-B1C9-0FC4AF22D2C1Q35666444-429EB7F0-6C45-4469-8427-CBE5B29A38B5Q35833250-17B65221-78AB-4AA9-81AB-2374E2DE77D5Q35875149-247BC8EB-7B5E-4C99-AE5B-D47651E3A613Q35940556-0E2CAE34-9ADC-4D70-8EC7-BF0C108EBE8EQ35991176-5D86F070-03B5-487A-8B29-23CBAC4D7B68Q36094861-2B72314E-A561-489E-9EB1-F747F2E1A6B0Q36267852-A3CFC503-2B6D-427F-A616-D0073291C7D7Q36291747-721D2644-5F52-4335-92D7-EFD5F0A7C637Q36789995-B4E47C6C-B19B-4627-A4A1-9AFB13D3015FQ36864125-5B1BCDE7-11E4-42A8-9F5F-EA485B65D97CQ37302581-D2EEA85F-698A-4398-83D1-E9945993F212Q37428282-8F31F3F3-0817-47DF-A687-398E240596B6Q38127663-E731B45C-FA37-4F7A-A2B7-F364A99F9CCCQ38636005-3233ECB9-8020-410E-BB28-673E063C87FFQ38793919-58E0EF0A-A9CC-40DD-BB4C-699D3E7F13DFQ39392178-5E89C5EC-493B-4526-B93E-2750BCC4D84AQ40082783-0C6BC318-3593-46A7-91DA-7FA6FD84D7A6Q40235194-FC053E16-CDAE-4945-AF9C-A46333D211F0Q40264352-779B9562-16AA-483E-8297-86E84B7D1CAAQ40891194-F24848BE-8447-4B40-BA2F-EDFF3A5A064BQ42277138-675906DC-82B8-4B20-8D17-97B05CB53069Q44022634-FF605D3E-9F15-4856-B1E9-85496879D44CQ44029839-DB63BB01-27C4-42E9-AF54-314A4F780261Q45331165-4ED94A08-787D-4B9E-AF5F-96C2EA3E0E39Q46366739-61D67586-CE21-40A9-B37D-D7332FFB299DQ46914675-91CF6799-D15D-4775-8AF0-F8621F485339Q46958410-802F3A4A-1B15-45C4-A7B6-A5B2D6B17D18Q50543736-A705448C-5A72-4FF4-84FE-DC9D5E71FA79
P2860
Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Role of comorbidity in mortali ...... weighted index of comorbidity.
@en
Role of comorbidity in mortali ...... weighted index of comorbidity.
@nl
type
label
Role of comorbidity in mortali ...... weighted index of comorbidity.
@en
Role of comorbidity in mortali ...... weighted index of comorbidity.
@nl
prefLabel
Role of comorbidity in mortali ...... weighted index of comorbidity.
@en
Role of comorbidity in mortali ...... weighted index of comorbidity.
@nl
P2093
P2860
P356
P1476
Role of comorbidity in mortali ...... weighted index of comorbidity.
@en
P2093
Colm Bergin
Cédric Methlin
Daniel Christmann
Martin Martinot
Olivier Lesens
Pierre Meyer
Véronique Remy
Yves Hansmann
P2860
P304
P356
10.1086/502156
P577
2003-12-01T00:00:00Z